Alivernini, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 5.552
AS - Asia 3.542
EU - Europa 3.369
SA - Sud America 750
Continente sconosciuto - Info sul continente non disponibili 188
AF - Africa 111
OC - Oceania 6
AN - Antartide 1
Totale 13.519
Nazione #
US - Stati Uniti d'America 5.367
SG - Singapore 1.622
IT - Italia 825
CN - Cina 812
BR - Brasile 607
SE - Svezia 481
DE - Germania 409
PL - Polonia 406
FR - Francia 395
VN - Vietnam 346
IE - Irlanda 164
GB - Regno Unito 160
IN - India 130
HK - Hong Kong 118
FI - Finlandia 113
BD - Bangladesh 101
UA - Ucraina 100
ID - Indonesia 97
CA - Canada 82
RU - Federazione Russa 77
JP - Giappone 74
MX - Messico 54
AR - Argentina 48
NL - Olanda 46
TR - Turchia 42
IQ - Iraq 40
ZA - Sudafrica 37
BE - Belgio 31
AT - Austria 29
KR - Corea 28
ES - Italia 25
EC - Ecuador 23
VE - Venezuela 18
PK - Pakistan 17
LT - Lituania 16
CH - Svizzera 15
CI - Costa d'Avorio 15
IR - Iran 15
CO - Colombia 14
IL - Israele 14
MA - Marocco 13
PE - Perù 11
TN - Tunisia 11
CL - Cile 10
SA - Arabia Saudita 10
CZ - Repubblica Ceca 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
GR - Grecia 8
HN - Honduras 8
KE - Kenya 8
PH - Filippine 8
UZ - Uzbekistan 8
JM - Giamaica 7
PT - Portogallo 7
UY - Uruguay 7
MY - Malesia 6
PY - Paraguay 6
TW - Taiwan 6
AL - Albania 5
AU - Australia 5
BO - Bolivia 5
CR - Costa Rica 5
EE - Estonia 5
KZ - Kazakistan 5
LV - Lettonia 5
MD - Moldavia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
DK - Danimarca 4
HU - Ungheria 4
JO - Giordania 4
NI - Nicaragua 4
NP - Nepal 4
TT - Trinidad e Tobago 4
AO - Angola 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
EG - Egitto 3
GE - Georgia 3
GT - Guatemala 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
PA - Panama 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MM - Myanmar 2
OM - Oman 2
Totale 13.308
Città #
Singapore 897
Ashburn 586
Chandler 508
San Jose 473
Warsaw 379
Rome 196
New York 186
Fairfield 168
Beijing 153
Los Angeles 148
Dublin 146
Wilmington 120
Ho Chi Minh City 112
Milan 105
Dallas 104
Dearborn 104
Hong Kong 104
The Dalles 102
Chicago 99
Woodbridge 98
Seattle 97
Ann Arbor 96
Jakarta 91
Lauterbourg 87
Houston 82
Hanoi 77
Nanjing 72
Cambridge 69
Hefei 69
Munich 65
Tokyo 63
Cattolica 62
São Paulo 61
Jacksonville 56
Boston 55
Frankfurt am Main 53
San Mateo 53
Helsinki 51
Princeton 50
Bremen 44
London 42
Council Bluffs 38
Marseille 37
North Bergen 30
Santa Clara 30
Moscow 29
Orem 29
Atlanta 28
Phoenix 28
Redwood City 28
Boardman 26
Paris 26
Brussels 25
Buffalo 24
Izmir 24
Nuremberg 24
Pune 24
Tianjin 24
Toronto 24
Lappeenranta 23
Montreal 23
Shanghai 23
Redmond 22
Denver 21
Seoul 21
Chennai 20
Haiphong 20
Lawrence 19
Nanchang 19
Stockholm 19
Da Nang 18
Johannesburg 18
Baghdad 17
Salt Lake City 17
Brasília 16
Guangzhou 16
Kunming 16
Turku 16
Abidjan 15
Norwalk 15
San Francisco 15
Shenyang 15
St Louis 15
Brooklyn 14
Elk Grove Village 14
Hangzhou 14
Kent 14
Lancaster 14
Mexico City 14
Tukwila 14
Vienna 14
Amsterdam 13
San Diego 12
Andover 11
Curitiba 11
Mountain View 11
Roubaix 11
Washington 11
Dhaka 10
Dong Ket 10
Totale 7.332
Nome #
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 416
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 353
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 348
The pathogenesis of rheumatoid arthritis 311
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 310
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 269
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 269
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 265
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 243
Synovial tissue macrophages: friend or foe? 218
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 216
COVID-19 atypical Parsonage-Turner syndrome: a case report 212
A single cell atlas of frozen shoulder capsule identifies features associated with inflammatory fibrosis resolution 211
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 209
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 209
Malnutrition in COVID-19 survivors: prevalence and risk factors 207
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 204
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 195
Malnutrition in COVID-19 survivors: prevalence and risk factors 185
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 184
Bispecific T cell engager therapy for refractory rheumatoid arthritis 180
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 179
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 175
Sarilumab use in severe SARS-CoV-2 pneumonia 170
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 169
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 162
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 162
Postural control and disability in patients with early rheumatoid arthritis 162
Has shoulder ultrasonography got a predictive value in Polymialgia Rheumatica. In: EULAR. 158
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 158
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 156
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 149
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 147
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 145
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 144
Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission 143
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 141
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 135
Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages 134
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 133
Comparative analysis of synovial inflammation after SARS-CoV-2 infection 131
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 130
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 128
Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis 127
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 127
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 127
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 126
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 125
Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study 125
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 125
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 122
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 122
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 119
null 118
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 117
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 117
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 117
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 116
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 116
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 114
Using explainable artificial intelligence to predict and forestall flare in rheumatoid arthritis 106
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases 106
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 104
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 101
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 98
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 98
RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection 98
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations 95
Ultrasound assessment as predictor of disease relapse in children and adults with arthritis in clinical stable remission: new findings but still unmet needs 95
Should rheumatoid factor (RF) (and antinuclear antibodies (ANA)) become routinary screening test for morbidities in the general population?: From the concept of “benign autoimmunity “to the concept of” autoimmunity as a red flag in preventive medicine”? 94
Laboratory Monitoring of Biological Therapies in Rheumatology: The Role of Immunogenicity 94
The B side of rheumatoid arthritis pathogenesis 94
JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy 93
A multiparametric risk table for loss of clinical remission status in patients with rheumatoid arthritis: A starter study post-hoc analysis 92
Biomarkers of joint damage in rheumatoid arthritis: where are we in 2013? 91
Telemedicine will not keep us apart in COVID-19 pandemic 91
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis 91
Loss of α2-6 sialylation promotes the transformation of synovial fibroblasts into a pro-inflammatory phenotype in arthritis 89
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons 87
Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis 87
Ecografia delle spalle in pazienti con PR: valore diagnostico ma non predittivo 86
Exploring perinatal mesenchymal stromal cells as a potential therapeutic strategy for rheumatoid arthritis 80
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 80
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 77
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 75
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 75
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis 75
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes 71
Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48 69
Driving chronicity in rheumatoid arthritis: Perpetuating role of myeloid cells 68
High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study 68
Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing 51
Evaluating antirheumatic treatments using synovial biopsy: A recommendation for standardisation to be used in clinical trials 50
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 47
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology 21
Minimally invasive ultrasound-guided biopsy of the common extensor tendon enthesis: a cadaveric study to standardise the technique 16
COVID-19 illness: Different comorbidities may require different immunological therapeutic targets 9
No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic 6
COVID‐19 illness: Different comorbidities may require different immunological therapeutic targets 6
Totale 13.519
Categoria #
all - tutte 59.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.066


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022624 0 46 32 52 45 18 15 74 44 51 97 150
2022/20231.525 177 184 114 231 115 187 65 121 191 62 51 27
2023/20241.056 42 219 50 52 43 189 96 37 39 70 141 78
2024/20252.054 36 38 152 97 149 83 90 88 303 230 391 397
2025/20265.091 735 194 367 617 805 292 802 252 270 369 184 204
2026/2027777 212 565 0 0 0 0 0 0 0 0 0 0
Totale 13.519